Clinical Trials Directory

Trials / Completed

CompletedNCT00275171

rhTSH, Radioiodine Uptake and Goiter Reduction Following 131I Therapy in Patients With Benign Nontoxic Nodular Goiter

The Effect of 0.1 mg Recombinant Human Thyrotropin (rhTSH) on Thyroid Radioiodine-uptake and the Degree of Goiter Reduction Following 131I-therapy, in Patients With Benign Non-toxic Nodular Goiter. A Randomized, Double-blind, Placebo-controlled Trial.

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Steen Bonnema · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study aims at clarifying (in a randomized, double-blinded design): 1. Whether stimulation with 0.1 mg rhTSH 24, 48 or 72 hours before induction of a 131I-tracer dosis increases the 131I uptake in patients with atoxic multinodular goitre and to study which time interval is the most optimal (Part I) 2. Whether patients suffering from atoxic multinodular goitre obtains a corresponding goitre reduction compared with a control group when stimulating with 0.1 mg rh TSH 24, 48 or 72 hours before 131I therapy and when reducing the thyroid radiation dose to 50 Gy (Part II) The two studies will be carried out successively on the same patient population. The 131I uptake will be carried out first followed by the I therapy itself. The patients are compared with a placebo-treated control group going through the same course of treatment, but the 131I dosis will be 100 Gy (standard treatment). After the 131I therapy, all patients are followed during one year with a regular ultrasound scan of the thyroid gland and control of the metabolic status. The patient satisfaction is monitored by the use of a visual-analogue-scale.

Conditions

Interventions

TypeNameDescription
DRUGRecombinant human thyrotropin (Thyrogen)0.1 mg rhTSH administered intramuscularly
DRUGrecombinant human TSH0.1 mg rhTSH administered intramuscularly
OTHERisotonic saline = placebo0.1 mg isotonic saline injected intramuscularly

Timeline

Start date
2006-02-01
Primary completion
2009-04-01
Completion
2009-09-01
First posted
2006-01-11
Last updated
2013-12-04

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00275171. Inclusion in this directory is not an endorsement.